comparemela.com
Home
Live Updates
BioCentriq Releases Results of Study Designed to Test Transfection of T-cells Using Kytopens Flowfect® Technology : comparemela.com
BioCentriq Releases Results of Study Designed to Test Transfection of T-cells Using Kytopen's Flowfect® Technology
/PRNewswire/ -- BioCentriq, Inc.—a New Jersey-based, cell and gene therapy contract development and manufacturing organization (CDMO)—announced today that...
Related Keywords
South Korea ,
Alex Klarer ,
Kytopen Flowfect ,
Biocentriq Inc ,
,
New Jersey Based ,
Large Scale Transfection ,
T Cells Using Flowfect ,
Advanced Therapies ,
Business Strategy ,
Bethany Grant ,
Chief Technology Officer ,
Biocentriq ,
comparemela.com © 2020. All Rights Reserved.